SESSION TITLE: Impact of Pleural Disorders
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Monday, October 24, 2016 at 07:30 AM - 08:30 AM
PURPOSE: Serositis is an uncommon and poorly described manifestation of chronic graft-versus-host disease (cGVHD) after allogenic hematopoietic stem cell transplant (HSCT). Little is known about cGVHD-associated serositis regarding incidence, risk factors, clinical characteristics or laboratory findings. In addition, no specific therapy is currently available. An improved understanding of cGVHD-associated serositis may allow for earlier detection and identification of novel therapies. We undertook this study to examine our experience of cGVHD-associated serositis at the University of Minnesota.